Literature DB >> 34907316

IMI European Lead Factory - democratizing access to high-throughput screening.

Philip S Jones, Sylviane Boucharens, Stuart P McElroy, Angus Morrison, Saman Honarnejad, Stan van Boeckel, Helma van den Hurk, Daniel Basting, Jörg Hüser, Stefan Jaroch, Eckhard Ottow, Jorg Benningshof, Rutger H A Folmer, Frank Leemhuis, Patricia M Kramer-Verhulst, Vera J M Nies, Kristina M Orrling, Ton Rijnders, Claudia Pfander, Ola Engkvist, Garry Pairaudeau, Peter B Simpson, Jean-Yves Ortholand, Didier Roche, Alexander Dömling, Sven M Kühnert, Peter W M Roevens, Herman van Vlijmen, Eva J A van Wanrooij, Christophe Verbruggen, Peter Nussbaumer, Huib Ovaa, Mario van der Stelt, Klaus Baek Simonsen, Lena Tagmose, Herbert Waldmann, James Duffy, Dirk Finsinger, Mirek Jurzak, Nicola A Burgess-Brown, Wen H Lee, Floris P J T Rutjes, Hubert Haag, Christopher Kallus, Hartmut Mors, Thierry Dorval, Brigitte Lesur, Fernando Ramon Olayo, Daniel Hamza, Geraint Jones, Christopher Pearce, Alexander Piechot, Dimitrios Tzalis, Mads H Clausen, Jeremy Davis, Daphné Derouane, Céline Vermeiren, Markus Kaiser, Robert A Stockman, Denise V Barrault, Andrew D Pannifer, Jason R Swedlow, Adam S Nelson, Romano V A Orru, Eelco Ruijter, Steven P van Helden, Volkhart M Li, Ton Vries, Jon S B de Vlieger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34907316     DOI: 10.1038/d41573-021-00196-3

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

Review 1.  Impact of high-throughput screening in biomedical research.

Authors:  Ricardo Macarron; Martyn N Banks; Dejan Bojanic; David J Burns; Dragan A Cirovic; Tina Garyantes; Darren V S Green; Robert P Hertzberg; William P Janzen; Jeff W Paslay; Ulrich Schopfer; G Sitta Sittampalam
Journal:  Nat Rev Drug Discov       Date:  2011-03       Impact factor: 84.694

2.  2020 FDA drug approvals.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2021-02       Impact factor: 84.694

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.